MirZyme Therapeutics

MirZyme Therapeutics UK Ltd biotech company working to improve maternal health and save lives by its pursuit of pioneering science to transform medicine.

From our COO on   ❤️ Happy International Women’s day ❣️
08/03/2025

From our COO on ❤️ Happy International Women’s day ❣️

Today, on May 22nd, MirZyme Therapeutics joins the global community in observing Preeclampsia Awareness Day, an occasion...
22/05/2024

Today, on May 22nd, MirZyme Therapeutics joins the global community in observing Preeclampsia Awareness Day, an occasion to shed light on a condition that profoundly impacts the lives of millions of women and infants worldwide.

Preeclampsia is a hypertensive disorder that typically occurs after the 20th week of pregnancy, characterised by high blood pressure and often signs of damage to another organ system, most commonly the liver and kidneys. This condition affects approximately 5-8% of pregnancies globally, making it a significant concern in maternal health.

Beyond its immediate health implications, preeclampsia can have long-term effects on both mothers and infants. For women, it increases the risk of cardiovascular disease later in life, while infants born to mothers with preeclampsia are more likely to be premature and have low birth weights, which can lead to a host of health complications. Furthermore, the economic burden of managing preeclampsia and its associated complications extends to healthcare systems and society at large.

At MirZyme Therapeutics, we are committed to make preeclampsia history with our One Test. One Pill. Save Two Lives. By leveraging our patented technology and know-how, we can accurately diagnose and treat preeclampsia, ultimately improving outcomes for mothers and infants. Our dedication to this mission is driven not only by scientific ambition but also by a profound sense of responsibility to the women and families affected by this condition.

As we mark Preeclampsia Awareness Day, let us reaffirm our commitment to raising awareness, supporting research, and advocating for policies that prioritise maternal health. Together, we can work to make preeclampsia history.

MirZyme Therapeutics and our founder Prof Asif Ahmed PhD FRSB wish you a very Happy Diwali.  
24/10/2022

MirZyme Therapeutics and our founder Prof Asif Ahmed PhD FRSB wish you a very Happy Diwali.

 

Next Wednesday, we are in Boston presenting to the Innovation Council of Ferring Pharmaceuticals and then MirZyme Therap...
24/09/2022

Next Wednesday, we are in Boston presenting to the Innovation Council of Ferring Pharmaceuticals and then MirZyme Therapeutics as one of the finalists at the Women's Health Innovation Series Summit USA and present to VCs, entrepreneurs and NGOs at the summit.

Congratulations to all the other FemTech startups who made it to the finals. Looking forward to seeing and speaking with you at the up coming event in Boston at the .

Address

Birmingham
B74BB

Alerts

Be the first to know and let us send you an email when MirZyme Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MirZyme Therapeutics:

Share